COMMUNIQUÉS West-GlobeNewswire

SBC Medical Group Holdings, Inc. Purchases 5 BTC
14/04/2025
IRVINE,Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Headquarters: California, USA; CEO: Yoshiyuki Aikawa) hereby announces that, based on the announcement of a decision to purchase Bitcoin (BTC [...]
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
14/04/2025
BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor [...]
Elutia Confirms No Material Impact from Global Tariffs
14/04/2025
SILVER SPRING, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today confirmed that the ongoing global tariff environment has [...]
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
14/04/2025
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens [...]
Relmada Therapeutics To Present NDV-01 Data at AUA2025
14/04/2025
Data to be presented on Monday, April 28, 2025 CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today [...]
Avicanna Reports Full Year 2024 Audited Financial Statement
14/04/2025
2024 Revenue of $25.5M, a 52% increase from 2023 Consolidated Gross Margins of 51%, Gross Profits of $12.9M, a 94% increase from 2023 TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ [...]
SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)
14/04/2025
DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell [...]
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
14/04/2025
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate [...]
10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer
14/04/2025
BEND, Ore., April 14, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing , a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), introduces Camp Coldie , 10 Barrel Brewing Co.’s highly-crushable new 5% IPA [...]
Castle Biosciences to Release First Quarter 2025 Financial Results and Host Conference Call on Monday, May 5, 2025
14/04/2025
FRIENDSWOOD, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its [...]
Soleno Therapeutics Announces VYKAT(TM) XR Launch
14/04/2025
First prescriptions delivered to individuals with PWS REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics [...]
Skye Bioscience to Conduct Meetings at Piper Sandler Conference
14/04/2025
SAN DIEGO, April 14, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic [...]
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer
14/04/2025
25+ years of experience in executive leadership roles and developing global strategic growth plans with repeatable models applicable across markets, categories and channels Current President and CEO, Gilles Gagnon to [...]
ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
14/04/2025
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its [...]
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
14/04/2025
Board of Directors has approved plan to liquidate and intends to seek stockholder approval for dissolution of the Company at the Annual Meeting of Stockholders on June 5, 2025 Initial distribution expected in the range [...]
Transactions under Novonesis’ share buyback program
14/04/2025
Please read the announcement in PDF Attachment 2025_18_Share_buyback_program
CORRECTION - New Guideline Aims to Transform Obesity Care for Children and Adolescents
14/04/2025
First Canadian update in nearly 20 years prioritizes improvements in health and quality of life over weight loss outcomes EDMONTON, Alberta, April 14, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline [...]
European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy
14/04/2025
Approval based on Phase III STARGLO study where Columvi in combination with chemotherapy showed a 41% reduction in the risk of death compared to MabThera/Rituxan plus chemotherapy 1,2 DLBCL is an aggressive cancer with [...]
Press release: CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases
14/04/2025
CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2026 Rule, expected to be finalized in [...]

Pages